Group 1 - The 2025 Xiamen Industrial Expo, the largest industrial exchange event across the Taiwan Strait, opened on May 9 at the Xiamen International Exhibition Center [1] - The expo features strategic cooperation with two major exhibition companies, enhancing the coverage of the entire industry chain through concurrent specialized exhibitions [1] - The event attracted over 800 leading brands from more than 10 countries and regions, with an exhibition area of 76,000 square meters [2] Group 2 - The expo adopted an "1+N" exhibition structure, showcasing a gradient display matrix of "World's Top 500 + Specialized Champions + Specialized New" [2] - Notable participants include international and domestic brands such as Yamazaki Mazak, American Hauser, and Huawei, with over 20 conferences scheduled during the event [2] - The 2025 Cross-Strait Industrial Forum will discuss "Artificial Intelligence Empowering New Industrialization," promoting technical exchanges and industrial collaboration [2] Group 3 - The Xiamen International Exhibition Center is a model for smart venues, featuring 26 intelligent subsystems and an IOC smart operation center for real-time monitoring [3] - The venue enhances visitor experience through smart navigation, real-time information push, and dynamic presentation of exhibition and exhibitor status [3] - The expo leverages the advantages of a "new generation digital exhibition hall" to significantly improve the exhibition experience [3]

Core Viewpoint - The "Implementation Plan for the Digital and Intelligent Transformation of the Pharmaceutical Industry (2025-2030)" aims for comprehensive digital transformation of large-scale pharmaceutical enterprises by 2030, enhancing competitiveness and ensuring drug quality and supply security [1][2] Group 1: Development Goals - By 2027, significant progress in digital transformation is expected, including breakthroughs in key technologies and the development of over 100 high-performance products in smart pharmaceutical equipment and software [1] - More than 100 intelligent pharmaceutical factories and over 10 innovation platforms for pharmaceutical models and technology applications are to be established by 2027 [1] - By 2030, large-scale pharmaceutical enterprises are expected to achieve full coverage of digital transformation, with enhanced innovation capabilities and a more complete data system across the pharmaceutical industry [1] Group 2: Specific Actions - The plan outlines 14 specific tasks focusing on four main areas: empowering actions through digital technology, promoting digital transformation, building a digital service system, and enhancing digital supervision [2] - It encourages collaboration among pharmaceutical companies, medical institutions, and research institutes to build a pharmaceutical big data platform for high-quality data collection across various fields [2] - The establishment of high-performance cloud computing platforms, blockchain, data centers, and other information infrastructure is encouraged to support the digital transformation of pharmaceutical enterprises [2] Group 3: Policy Support - The Ministry of Industry and Information Technology will strengthen policy coordination and increase support for the digital transformation of the pharmaceutical industry through national science and technology projects [2] - Local governments are encouraged to enhance resource support and promote cross-regional cooperation among pharmaceutical enterprises and their supply chains [2] - The plan also aims to align domestic and international regulations, standards, and technical exchanges in the field of pharmaceutical digitalization [2]